Literature DB >> 15213404

Crystallization and preliminary X-ray diffraction study of mammalian mitochondrial seryl-tRNA synthetase.

Sarin Chimnaronk1, Mads Gravers Jeppesen, Nobukazu Shimada, Tsutomu Suzuki, Jens Nyborg, Kimitsuna Watanabe.   

Abstract

The mitochondrial seryl-tRNA synthetase (mt SerRS) from Bos taurus was overexpressed in Escherichia coli and crystallized using the sitting-drop vapour-diffusion method. Crystals grew in a very narrow range of conditions using PEG 8000 as precipitant at room temperature. An appropriate concentration of lithium sulfate was critical for crystal nucleation. Crystals diffracted well beyond a resolution of 1.6 A and were found to belong to the orthorhombic space group C222(1), with unit-cell parameters a = 79.89, b = 230.42, c = 135.60 A. There is one dimer (M(r) approximately 113 kDa) in the asymmetric unit, with a solvent content of 55%. Efforts to solve the phase problem by molecular replacement are under way.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15213404     DOI: 10.1107/S0907444904011217

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  3 in total

1.  Tyrosyl-tRNA synthetase: the first crystallization of a human mitochondrial aminoacyl-tRNA synthetase.

Authors:  Luc Bonnefond; Magali Frugier; Elodie Touzé; Bernard Lorber; Catherine Florentz; Richard Giegé; Joëlle Rudinger-Thirion; Claude Sauter
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-03-30

2.  Dual-mode recognition of noncanonical tRNAs(Ser) by seryl-tRNA synthetase in mammalian mitochondria.

Authors:  Sarin Chimnaronk; Mads Gravers Jeppesen; Tsutomu Suzuki; Jens Nyborg; Kimitsuna Watanabe
Journal:  EMBO J       Date:  2005-09-15       Impact factor: 11.598

Review 3.  When a common biological role does not imply common disease outcomes: Disparate pathology linked to human mitochondrial aminoacyl-tRNA synthetases.

Authors:  Ligia Elena González-Serrano; Joseph W Chihade; Marie Sissler
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.